A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: Case report.
alopecia areata
intralesional triamcinolone acetonide
linear lesion
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
08
07
2020
revised:
17
10
2020
accepted:
30
10
2020
pubmed:
12
11
2020
medline:
20
4
2021
entrez:
11
11
2020
Statut:
ppublish
Résumé
Intralesional steroid injection is a treatment method frequently used to resolve a large number of orthopedic, rheumatological, dermatological, and neurological disorders. Although this treatment is very effective, it is not without possible side effects, both systemic and local, among which we can mention pain, bleeding, ulceration, atrophy, pigmentary changes, calcification, secondary infections, formation of granulomas, allergic reactions and, in very rare cases, the development of linear atrophy, and hypopigmentation. Here, we present a case of frontal linear skin atrophy after intralesional steroid injection for the treatment of alopecia areata (AA) in a 29 year-old patient, successfully treated with a hyaluronic acid filler.
Substances chimiques
Glucocorticoids
0
Hyaluronic Acid
9004-61-9
Triamcinolone Acetonide
F446C597KA
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14526Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Jang WS, Park J, Yoo KH, et al. Branch-shaped cutaneous hypopigmentation and atrophy after intralesional triamcinolone injection. Ann Dermatol. 2011;23(1):111-114. https://doi.org/10.5021/ad.2011.23.1.111.
Gupta AK, Carviel JL, Foley KA, et al. Monotherapy for alopecia Areata: a systematic review and network meta-analysis. Skin Appendage Disord. 2019;5(6):331-337. https://doi.org/10.1159/000501940.
Gupta AK, Carviel J, Abramovits W. Treating alopecia areata: current practices versus new directions. Am J Clin Dermatol. 2017;18(1):67-75. https://doi.org/10.1007/s40257-016-0230-4.
Pirmez R, Abraham LS, Duque-Estrada B, et al. Trichoscopy of steroid-induced atrophy. Skin Appendage Disord. 2017;3(4):171-174. https://doi.org/10.1159/000471771.
Jha AK, Udayan UK, Roy PK, Amar AKJ, Chaudhary RKP. Dermoscopy of alopecia areata-a retrospective analysis. Dermatol Pract Concept. 2017;7(2):53-57. https://doi.org/10.5826/dpc.0702a12.
Inui S. Trichoscopy for common hair loss diseases: algorithmic method for diagnosis. J Dermatol. 2011;38(1):71-75. https://doi.org/10.1111/j.1346-8138.2010.01119.x.
Suchonwanit P, Iamsumang W, Leerunyakul K. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature. J Dermatolog Treat. 2020;1-6. https://doi.org/10.1080/09546634.2020.1782324.
Suchonwanit P, Kositkuljorn C, Mahasaksiri T, Leerunyakul K. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. J Dermatolog Treat. 2020;1-6. https://doi.org/10.1080/09546634.2020.1773384.
Kikuchi I, Horikawa S. Letter: Perilymphatic atrophy of the skin. Arch Dermatol. 1975;111(6):795-796. https://doi.org/10.1001/archderm.1975.01630180123027.
Ayres S Jr. Alopecia areata with associated subcutaneous atrophy. Arch Dermatol. 1964;90:242.
Dhawan AK, Bisherwal K, Grover C, Tanveer N. Linear Leucoderma following Intralesional steroid: a report of three cases. J Cutan Aesthet Surg. 2015;8(2):117-119. https://doi.org/10.4103/0974-2077.158453.